Sunshine Biopharma Inc. (SBFMW) Return on equity 2021–2025
Sunshine Biopharma Inc. (SBFMW) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-25.9%FY2025 · since FY2021: -5875.6% → -25.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -25.9% | -4.1 pp |
| FY2024 | -21.8% | -0.6 pp |
| FY2023 | -21.2% | +102.4 pp |
| FY2022 | -123.7% | +5752.0 pp |
| FY2021 | -5875.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More SBFMW financial trends
SBFMW RevenueSBFMW Net incomeSBFMW Net marginSBFMW Gross profitSBFMW Gross marginSBFMW Operating incomeSBFMW Operating marginSBFMW Operating cash flowSBFMW Free cash flowSBFMW Capital expendituresSBFMW Stock buybacksSBFMW Dividends paidSBFMW Total assetsSBFMW Total liabilitiesSBFMW Shareholders’ equitySBFMW overview →